CYCLICAL ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS IN PRIMARY BILIARY-CIRRHOSIS

被引：1
|
作者：
WOLFHAGEN, FHJ
DENOUDEN, JW
VANBUUREN, HR
VANLEEUWEN, JPTM
SCHALM, SW
POLS, HAP
机构：
[1] ST FRANCISCUS HOSP, DEPT INTERNAL MED, ROTTERDAM, NETHERLANDS
[2] UNIV HOSP ROTTERDAM, DEPT INTERNAL MED, ROTTERDAM, NETHERLANDS
[3] UNIV HOSP ROTTERDAM, HEPATOL SECT, ROTTERDAM, NETHERLANDS
[4] UNIV HOSP ROTTERDAM, CLIN ENDOCRINOL SECT, ROTTERDAM, NETHERLANDS
来源：
GASTROENTEROLOGY | 1995年 / 108卷 / 04期
关键词：
D O I：
10.1016/0016-5085(95)29099-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1199 / A1199
页数：1
相关论文
共 50 条
  • [1] INTERMITTENT CYCLICAL ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS
    MULDER, H
    STRUYS, A
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (04): : 348 - 350
  • [2] The prevention of corticosteroid-induced bone loss with intermittent cyclical etidronate
    Jenkins, EA
    Walker-Bone, KE
    Wood, A
    McCrae, FC
    Cooper, C
    Cawley, MID
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1999, 28 (03) : 152 - 156
  • [3] Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss
    Roux, C
    Oriente, P
    Laan, R
    Hughes, RA
    Ittner, J
    Goemaere, S
    Di Munno, O
    Pouillès, JM
    Horlait, S
    Corter, B
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04): : 1128 - 1133
  • [4] Cyclical etidronate therapy in the prevention and treatment of corticosteroid-induced osteoporosis
    Adachi, JD
    REVIEWS IN CONTEMPORARY PHARMACOTHERAPY, 1998, 9 (04): : 267 - 275
  • [5] INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS
    ADACHI, JD
    CRANNEY, A
    GOLDSMITH, CH
    BENSEN, WG
    BIANCHI, F
    CIVIDINO, A
    CRAIG, GL
    KAMINSKA, E
    SEBALDT, RJ
    PAPAIOANNOU, A
    BORATTO, M
    GORDON, M
    STEELE, M
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (10) : 1922 - 1926
  • [6] Intermittent cyclical therapy with etidronate in the prevention of corticosteroid-induced osteoporosis.
    Bensen, WG
    Adachi, JD
    Anastassiades, TP
    Brown, JP
    Chines, AA
    Olszynski, WP
    Hanly, JG
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1773 - 1773
  • [7] Intermittent cyclical etidronate therapy in the prevention and treatment of corticosteroid-induced osteoporosis.
    Adachi, J
    Roux, C
    Moniz, C
    Geusens, P
    Dequeker, J
    Webber, D
    Pack, S
    Ethgen, D
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 628 - 628
  • [8] CYCLICAL ETIDRONATE REVERSES BONE LOSS OF THE SPINE AND PROXIMAL FEMUR IN PATIENTS WITH ESTABLISHED CORTICOSTEROID-INDUCED OSTEOPOROSIS
    STRUYS, A
    SNELDER, AA
    MULDER, H
    AMERICAN JOURNAL OF MEDICINE, 1995, 99 (03): : 235 - 242
  • [9] Cyclic etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis - A prospective, controlled pilot study
    Wolfhagen, FHJ
    vanBuuren, HR
    denOuden, JW
    Hop, WCJ
    vanLeeuwen, JPTM
    Schalm, SW
    Pols, HAP
    JOURNAL OF HEPATOLOGY, 1997, 26 (02) : 325 - 330
  • [10] Intermittent cyclical therapy with etidronate prevents corticosteroid-induced bone loss: Three years of follow-up.
    Sebaldt, RJ
    Adachi, JD
    Boratto, M
    Gordon, M
    Steele, M
    Stephenson, GF
    Goldsmith, CH
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S302 - S302
12345